The National Cancer Institute’s “cancer moonshot” tasks researchers with, among advancing other new biotechnologies, delving into immunotherapy and epigenomic analysis.
The odds were stacked against Ruben Rodriguez. When the 27-year-old UC Merced student was still in high school, he was confronted with a sobering statistic that Hispanics receive only 5 percent of all doctorates awarded.